Ind-Swift Labs: No Deviation in Preferential Issue Fund Utilization

Ind-Swift Laboratories Ltd has confirmed no deviation or variation in the utilization of funds raised through its preferential issue of 70,00,000 Fully Convertible Warrants allotted on September 17, 2026. The total amount raised was Rs. 34.30 Crores out of a total issue size of Rs. 137.20 Crores. The funds were utilized for various objects including expansion of existing manufacturing facilities, research and development, technology upgradation, investment in a subsidiary, working capital requirements, and general corporate purposes. The 'Nil Statement of Deviation' for the quarter ended September 30, 2026, has been reviewed by the Audit Committee, and no discrepancies were found.